Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Glycosuria
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
53
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Myopia
|
disease |
Eye Diseases
|
Disease or Syndrome
|
490
|
167
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
3
|
2018 |
2018 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Autoantibody measurement
|
phenotype |
|
Laboratory Procedure
|
27
|
52
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Waist Circumference
|
phenotype |
|
Clinical Attribute
|
70
|
183
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Physical Activity Measurement
|
phenotype |
|
Laboratory Procedure
|
160
|
355
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Periodontitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
682
|
116
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adrenoleukodystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
294
|
116
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Intervertebral Disc Degeneration
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
342
|
47
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic nasopharyngitis
|
disease |
Infections; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |